Article
Increased expression of stomatin-like protein 2 (STOML2) predicts decreased survival in gastric adenocarcinoma: a retrospective study.
Medical oncology (Northwood, London, England) - 1 Jan 2014
Li Xiao-Hong, He Fan, Yan Shu-Mei, Li Yong, Cao Yun, Huang Chun-Yu, Zhou Zhi-Wei
Abstract excerpt
Stomatin-like protein 2 (STOML2), a member of the stomatin, has been reported to be upregulated in several human cancers. However, its role and clinical significance in gastric adenocarcinoma remains unclear to date. The purpose of this retrospective study was to explore whether there was a correlation between the expression of STOML2 by immunohistochemistry and the clinical outcome of a large group of patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
